Olprinone - CAS 106730-54-5
Catalog number: 106730-54-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Phosphodiesterase (PDE)
Olprinone(Loprinone) is a selective phosphodiesterase 3 (PDE3) inhibitor.
Publictions citing BOC Sciences Products
  • >> More
1. Synthesis of imidazo[1,2-a]pyridines: a decade update
Avik Kumar Bagdi, Sougata Santra, Kamarul Monir and Alakananda Hajra*. Chem. Commun., 2015, 51, 1555—1575
Imidazopyridine, the imidazole moiety fused with the pyridine ring, is an important biologically active nitrogen containing heterocycle. Among the various imidazopyridine derivatives, the imidazo[1,2-a]pyridine moiety is the most important in the area of natural products and pharmaceuticals. These derivatives show a wide range of biological activities such as anti-fungal, antiinflammatory, antitumor, antiviral, antibacterial, antiprotozoal, antipyretic, analgesic, antiapoptotic, hypnoselective, and anxioselective activities. They also act as b-amyloid formation inhibitors, GABA and benzodiazepine receptor agonists, and cardiotonic agents. There are several drugs such as zolpidem (1, used in the treatment of insomnia), alpidem (2, as an anxiolytic agent),olprinone (3, for the treatment of acute heart failure), zolimidine (4, used for the treatment of peptic ulcer), necopidem and saripidem (5 and 6, both work as an anxiolytic agent) available in the market which contain the imidazo[1,2-a]pyridine moiety (Fig. 1). The optically active GSK812397 is a drug for the treatment of HIV infection. The antibiotic drug Rifaximin also contains this fused heterocyclic moiety.
2. Cu-Catalyzed selective C3-formylation of imidazo[1,2-a]pyridine C–H bonds with DMSO using molecular oxygen
Hua Cao,* Sai Lei, Naiying Li, Longbin Chen. Chem. Commun., 2015, 51, 1823—1825
Our recent efforts included the construction of imidazo[1,2-a]-pyridines by direct C–H functionalization or the multicomponent reaction. Imidazo[1,2-a]pyridine and its derivatives as important fine chemicals have been found to be key structural units in many natural products and drugs, such as zolpidem, alpidem, zolimidine, olprinone, saripidem, and necopidem, and exhibit a broad range of biological activities. There has been long-standing interest in the development of new and efficient transformation for the synthesis of imidazo[1,2-a]pyridines due to their great important applications. In continuation of our interest in preparing imidazo[1,2-a]pyridine derivatives by direct C–H functionalization, we reported a novel and facile copper-catalyzed C-3 formylation of imidazo[1,2-a]pyridines with DMSO utilizing molecular oxygen as the terminal oxidant.
3. Ruthenium-catalyzed direct C-3 oxidative olefination of imidazo[1,2-a]pyridines
Haiying Zhan, Limin Zhao,* Naiying Li, Longbin Chen, Jingyun Liu, Jinqiang Liao and Hua Cao*. RSC Adv.,2014, 4, 32013–32016
We are particularly interested in the development of new catalytic transformation that exploit selective C–H functionalization to elaborate simple imidazo[1,2-a]pyridines to useful products. Imidazo[1,2-a]pyridine rings are among the most important heterocyclic structural motifs. It has been found to be key structural units inmany pharmaceuticals and exhibited a wide range of biological activities, such as zolpidem, zolimidine, and alpidem, necopidem, olprinone, and divalpon. Thus, the development of short and facile routes for the construction of imidazo[1,2-a]pyridine compounds through transition-metal-catalyzed functionalizations has received intensive attention. Among thesemetal, Pd, Au, Ag, and Cu is the favorable catalysts for the preparation of imidazo[1,2-a]pyridine derivatives. transition-metal-catalyzed transformation has been developed for the synthesis of imidazo[1,2-a]pyridine derivatives during the last few years, there has only been a rare example for the direct oleflnation of imidazo[1,2-a]pyridine.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Phosphodiesterase (PDE) Products

BRL 50481
(CAS: 433695-36-4)

BRL 50481 is a potent, selective substrate-competitive inhibitor of phosphodiesterase (PDE) 7 (Ki = 180 nM).

CAS 939055-18-2 FIPI

(CAS: 939055-18-2)

FIPI, a derivative of halopemide, is a potent and selective phospholipase D (PLD) inhibitor with IC50 values of 20 and 25 nM for PLD2 and PLD1 respectively. It ...

CAS 1144035-53-9 PF-8380

(CAS: 1144035-53-9)

PF-8380 blocks inflammation-induced LPA synthesis. PF-8380 works both in vitro and in vivo through direct inhibition of autotaxin. In human whole blood PF-8380 ...

CP-461 free base
(CAS: 227619-92-3)

CP 461, belonging to a class of novel proapoptotic drugs with antineoplastic effect, specifically inhibit cyclic GMP phosphodiesterases but not cyclooxygenase-1...

CAS 77671-31-9 Enoximone

(CAS: 77671-31-9)

Enoximone is a selective phosphodiesterase III (PDE3) inhibitor. It can be used for the treatment of heart failure.

CAS 862189-95-5 Mirodenafil

(CAS: 862189-95-5)

Mirodenafil is a newly developed oral phosphodiesterase type 5 (PDE-5) inhibitor developed for the treatment of erectile dysfunction. It significantly improved ...

CAS 139755-83-2 Sildenafil

(CAS: 139755-83-2)

An orally active selective type 5 cGMP phosphodiesterase inhibitor.

CAS 152633-54-0 Win-62005

(CAS: 152633-54-0)

Win-62005 competitively and selectively inhibits cyclic GMP-inhibitable low Km cyclic AMP phosphodiesterase (PDE III) from rat heart and canine aorta (Kis= 25 a...

CAS 1440898-61-2 Deltarasin

(CAS: 1440898-61-2)

Deltarasin inhibits the interaction of RAS with PDEδ with KD of 41 nM. Inhibition of PDEδ-KRAS interaction by Deltarasin suppresses proliferation of human pancr...

CAS 947620-48-6 RVT-501

(CAS: 947620-48-6)

RVT-501, also referred to E6005, is a selective phosphodiesterase 4 (PDE4) inhibitor (IC50= 2.8 nM) with potential effect to treat atopic dermatitis.

CAS 68475-42-3 Anagrelide

(CAS: 68475-42-3)

Anagrelide is a phosphodiesterase inhibitor with antiplatelet activity with IC50 value of 36 nM for inhibition of phosphodiesterase 3. It inhibits the maturatio...

CAS 189362-06-9 K134

(CAS: 189362-06-9)

K134 is a selective phosphodiesterase 3 (PDE3) inhibitor, and has been shown to exhibit more potent anti-platelet activity than cilostazol. In vivo studies have...

CAS 898563-00-3 TP-10

(CAS: 898563-00-3)

TP-10 is a PDE10A inhibitor with IC50 of 0.8 nM. It has extremely potent PDE10A inhibitory activity and high selectivity against other PDEs. It is active in the...

CAS 257892-33-4 AWD 12-281

AWD 12-281
(CAS: 257892-33-4)

AWD 12-281 is a strong selective phosphodiesterase 4 (PDE4) inhibitor which has potent effects in models of lung inflammation using inhalative administration.

CAS 119615-63-3 Olprinone Hydrochloride

Olprinone Hydrochloride
(CAS: 119615-63-3)

Olprinone is a selective phosphodiesterase 3 (PDE3) inhibitor. Olprinone is used as cardiotonic agent with positive inotropic and vasodilating effects. Olprinon...

(CAS: 799841-02-4)

FR-229934 is a Type 5 cyclic nucleotide phosphodiesterase inhibitor. In Feb 2008, preclinical for Erectile dysfunction in Japan was discontinued.

CAS 224785-90-4 Vardenafil HCl Trihydrate

Vardenafil HCl Trihydrate
(CAS: 224785-90-4)

Vardenafil HCl Trihydrate is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively. Vardenafil was co-marketed by Bayer Pharmaceu...

CAS 898562-94-2 PF-2545920

(CAS: 898562-94-2)

PF-2545920 a highly selective and potent PDE10A inhibitor. It was active with an ED50 of 1 mg/kg.

(CAS: 298680-25-8)

RPL 554 is a potent and selective PDE3/4 inhibitor for respiratory diseases, particularly in patients with asthma.

CAS 58579-51-4 Anagrelide Hydrochloride

Anagrelide Hydrochloride
(CAS: 58579-51-4)

Anagrelide is a drug used for the treatment of essential thrombocytosis,or overproduction of blood platelets. It also has been used in the treatment of chronic ...

Chemical Structure

CAS 106730-54-5 Olprinone

Quick Inquiry

Verification code

Featured Items